Aestetix
The computed 12-month bankruptcy probability of Aestetix is 0.1% (very low). The 2025 annual accounts show equity of €1.25M and a net result of €1.12M. Equity is growing by ~37% per year across the filed fiscal years. Its solvency ranks better than 94% of 87 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1.25M |
| Net result | €1.12M |
| Staff (FTE) | 1.3 |
| Better than sector | 94% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 96.0% | 56.8% | |
| Net result | €1.12M | €97k | |
| Equity | €1.25M | €207k | |
| Gross operating margin | €1.65M | €237k | |
| Staff costs | €58k | €98k |
| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €1.59M |
| Net profit | €1.12M |
| Cash flow | €1.21M |
| Staff costs | €58k |
| Income taxes | €380k |
| Dividends | - |
| Total assets | €1.30M |
| Equity | €1.25M |
| Debt | €51k |
| of which ≤ 1y | €49k |
| of which > 1y | - |
| Working capital | €785k |
| Employees (FTE) | 1.3 |
| 2025 | |
|---|---|
| Current ratio | 17.03 |
| Quick ratio | 14.02 |
| Working capital ratio | 60.5% |
| Solvency | 96.0% |
| Debt / equity | 0.04 |
| Long-term debt ratio | - |
| Interest coverage | 7839.59 |
| Gross margin | - |
| Net margin | - |
| ROA | 86.2% |
| ROE | 89.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.30M |
| Fixed assets | 21/28 | €464k |
| Tangible fixed assets | 22/27 | €453k |
| Financial fixed assets | 28 | €11k |
| Current assets | 29/58 | €834k |
| Stocks & contracts in progress | 3 | €147k |
| Amounts receivable within one year | 40/41 | €7k |
| Cash & bank | 54/58 | €582k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.30M |
| Equity | 10/15 | €1.25M |
| Contributions / capital | 10/11 | €1k |
| Reserves | 13 | €1.25M |
| Amounts payable | 17/49 | €51k |
| Amounts payable within one year | 42/48 | €49k |
| Trade debts payable within one year | 44 | €29k |
| Income statement | ||
| Gross operating margin | 9900 | €1.65M |
| Operating result | 9901 | €1.50M |
| Financial income | 75 | €3k |
| Financial charges | 65 | €203 |
| Result before taxes | 9903 | €1.50M |
| Income taxes | 67/77 | €380k |
| Net result for the period | 9904 | €1.12M |
| Result to be appropriated | 9905 | €762k |
| NACE primary | Activiteiten van medisch specialisten(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 07-12-2020 |
| Status | Active |
| Postal code | 9830 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44064B0232/00C000 | Flanders | 2,691 m² | 1 · 601 m² | 12.7 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
17-03-2023 Registered office moved from Roeselare to Sint-Martens-Latem
- Zuidmolenstraat 168, 8800 Roeselare → Kortrijksesteenweg 90 bus CD, 9830 Sint-Martens-Latem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Kortrijksesteenweg 90 bus CD, 9830 Sint-Martens-Latem",
"city": "Sint-Martens-Latem",
"region": "vlaams_gewest",
"street": "Kortrijksesteenweg",
"country": "BE",
"postcode": "9830",
"box_number": "CD",
"street_number": "90",
"locality_suffix": null
},
"old_address": {
"raw": "Zuidmolenstraat 168, 8800 Roeselare",
"city": "Roeselare",
"region": "vlaams_gewest",
"street": "Zuidmolenstraat",
"country": "BE",
"postcode": "8800",
"box_number": null,
"street_number": "168",
"locality_suffix": null
},
"effective_date": "2023-01-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "DR. DANIEL DIMOVSKI",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2023-03-07",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enige_bestuurder",
"date": "2023-01-01",
"unanimous": null
},
"subject_company": {
"kbo": "0759.529.497",
"name_full": null,
"legal_form": "BV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Dimovski Daniel",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Aestetix |